CONMED Corporation revised earnings guidance for the fiscal 2022. Based on the first quarter results, the Company is raising its revenue guidance for the full year 2022 and now expects revenue between $1.105 billion and $1.150 billion, compared to its prior guidance of between $1.075 billion and $1.125 billion. The Company now expects full-year 2022 adjusted diluted net earnings per share in the range of $3.50 to $3.65, compared to its prior range of $3.60 to $3.85.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
61.9 USD | -11.58% | -12.92% | -43.48% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-43.48% | 2.16B | |
-2.92% | 185B | |
-3.80% | 107B | |
-5.48% | 67.55B | |
+11.22% | 54.6B | |
+16.74% | 47.42B | |
+2.95% | 42.24B | |
+4.56% | 28.24B | |
+1.64% | 26.42B | |
+12.25% | 25.66B |
- Stock Market
- Equities
- CNMD Stock
- News CONMED Corporation
- CONMED Corporation Revised Earnings Guidance for the Fiscal 2022